CyberKnife radiosurgery offers a precise method of delivering high doses of radiation to prostate tumors, minimizing damage to surrounding healthy tissue. However, certain patient characteristics and disease states make this treatment option less suitable. These contraindications relate to disease stage, overall health, and anatomical factors that could compromise the effectiveness or safety of the procedure.
Understanding the situations where CyberKnife is less favorable is critical for ensuring optimal patient outcomes. Its selection requires careful evaluation of individual patient profiles and cancer characteristics. Alternative treatment modalities might offer superior benefits or reduced risks in specific clinical scenarios, highlighting the necessity for thorough pre-treatment assessment and informed decision-making between physicians and patients.
